NCT06369935 2024-04-17
A Real World Study of Equecabtagene Autoleucel in Subjects With Relapsed and Refractory Multiple Myeloma.
Peking University People's Hospital
Not yet recruiting
Clinical Trials
4 trialsNCT05698303 2023-01-26
A Study of Fully Human BCMA Chimeric Antigen Receptor Autologous T Cell Injection (CT103A) in the Treatment of Patients With Relapsed/Refractory Multiple Myeloma
Nanjing IASO Biotechnology Co., Ltd.
Phase 1 Unknown
NCT05181501 2022-01-06
A Study of Fully Human BCMA CAR-T (CT103A) in Patients With Newly Diagnosed High-risk Multiple Myeloma (FUMANBA-2)
Nanjing IASO Biotechnology Co., Ltd.
Phase 1 Not yet recruiting
NCT05066646 2021-11-23
FUMANBA-1
Nanjing IASO Biotechnology Co., Ltd.
Phase 1/2 Unknown